Primary Care Diabetes
Volume 2, Issue 3 , Pages 155-157 , September 2008

Falsely low HbA1c value due to a rare variant of hemoglobin J-Baltimore

Received 6 March 2008 ,Accepted 30 May 2008.

References 

  1. Arribalzaga K, Ricard MP, Carreno DL, et al. Hb J-Baltimore [beta 16(A13)Gly→Asp] associated with beta(+)-thalassemia in a Spanish family. Hemoglobin. 1996;20:79–84
  2. Baglioni C, Weatherall DJ. Abnormal human hemoglobins IX. Chemistry of hemoglobin JBaltimore. Biochim. Biophys. Acta. 1963;78:637–643
  3. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin. Chem. 2001;47:153–163
  4. Davis JE, McDonald JM, Jarett L. A high-performance liquid chromatography method for hemoglobin A1c. Diabetes. 1978;27:102–107
  5. Haliassos A, Drakopoulos I, Katritsis D, et al. Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants. Clin. Chem. Lab. Med. 2006;44:223–237
  6. Hall PM, Cook JG, Gould BJ. An inexpensive, rapid and precise affinity chromatography method for the measurement of glycosylated haemoglobins. Ann. Clin. Biochem. 1983;20:129–135
  7. Holman CA, Smith AJ, Whimster WF, et al. Hemoglobin J-Baltimore in a Kent family. Br. Med. J. 1964;2:921–922
  8. Menard L, Dempsey ME, Blankstein LA, et al. Quantitiative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clin. Chem. 1980;26:1598–1602
  9. Ou C-N, Rognerud CL. Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC. Clin. Chim. Acta. 2001;313:187–194
  10. Panzer S, Kronik G, Lechner K, et al. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood. 1982;59:1348–1350
  11. Parker KM, England JD, Da Costa J, et al. Improved colorimetric assay for glycosylated hemoglobin. Clin. Chem. 1981;27:669–672
  12. Rahbar S. The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann. N.Y. Acad. Sci. 2005;1043:9–19
  13. Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problem solved?. Clin. Chem. 2003;49:1245–1247
  14. Simon M, Cuan J. Hemoglobin A1C by isoelectric focusing. Clin. Chem. 1982;28:9–12
  15. Standing SJ, Taylor RP. Glycated haemoglobin: an assessment of high capacity liquid chromatographic and immunoassay methods. Ann. Clin. Biochem. 1992;29:494–505
  16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 1993;329:977–986
  17. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N. Eng. J. Med. 1971;287:353–357
  18. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  19. Wilkinson T, Kronenberg H, Isaacs WA, Lehmann H. Haemoglobin J Baltimore interacting with beta-thalassaemia in an Australian family. Med. J. Aust. 1967;1:907–910

PII: S1751-9918(08)00069-7

doi: 10.1016/j.pcd.2008.05.003

Primary Care Diabetes
Volume 2, Issue 3 , Pages 155-157 , September 2008

Article Tools